RMS 3system.png

 RMD

Rose Medical Devices 

About

RMD is a medical device company that provides solutions in the medical world resulting from the complete or partial immobility of patients, with an emphasis on pressure ulcers.

The company develops an AI monitoring diagnostic system and a non-invasive dynamic mechatronic surface to define a new standard for a patient body's pressure care.

 

 

The database analysis of patients’ immobility translated into an automated mechatronic treatment, creates a significant added value to the medical teams’ decisions enabling an active adjusted treatment plan for each patient.

 

Solution.png

Non-Invasive monitoring

Solution.png

Detecting organs at risk

Solution.png
Solution.png

Automated Treatment

Alerts & Reports

The system is divided into two separate modules which are synchronized and transmit information to each other, thereby providing a full system solution that monitors and actives a personal treatment to a patient.

 

Mapping.png

Diagnostic Module

 

An AI-powered diagnostic system captures and converts precise body pressure measurements into an output signal and provides real-time body infographic insights.

 

13.png

Mechatronic Surface Module

 

A dynamic surface that monitors a patient's body immobility and organs at high risk to develop pressure ulcers and activates an automated non-invasive pressures depreciation mechanism on these specific organs.

 

 
Turning Data Analysis into Mechatronic Treatments
LOGO.png

Did You Know?

1 Hour

Pressure ulcers appear within 1 hour of immobility

2.5M

Annually in the USA 2.5M people in care facilities suffer from pressure ulcers.

60K

Every year In the USA, 60K people die  from hospital-acquired pressure ulcers

11.6B

The USA economy spends $11.6 billion a year on pressure ulcers

Picture11.png

Current devices do not target specific organs but basically operate a constant movement airflow which creates a uniform pressure under the patient's body and no pressure depreciation for organs at high risk.

2.png

Medical Decisions are not based on precise AI mobility data analysis needed to make evidence-based decisions on improving patient conditions.

3.png

Treatment Processes are time-consuming since nurses regularly change patients' posture to avoid constant pressure on their bodies, and care tracking is made manually.

4.png

Treatment costs are 2.5 times higher than prevention. As well, hospitals have great exposure to lawsuits and non-reimbursement.

5.png

Hospital length of stay is on avg 4-day longer with a total of $17 000 additional incremental charges for the hospital admission.

LOGO.png

Mechatronic Surface Module

RMD Mechatronic solution offers effective monitoring and analysis of patient organs at high risk to develop pressure ulcers while integrating an automated non-invasive mechanism that continuously depreciates pressures on these specific organs.

treatmant.png

The AI-powered mechatronic surface is divided into individual static and dynamic units.

 

Each unit contains an integral self-learning microprocessor associated with a relevant electronic piston for analyzing real-time data of the patient’s body.

 

In accordance, the AI machine operates a preventative active mechanism treatment by adjusting the movement of each appropriate piston, located under the organ at risk.

The surface is designed to be integrated easily on top of any bed. It can be a complementary addition to smart beds or be used as a replacement for mattresses and thus enables to convert any bed into a smart bed.

Benefits

247 monitoring.png
target.png

Targeting specific organs at high to develop pressure ulcers and activating a  constant proactive treatment.

24/7 monitoring, recording treatment history, data analysis reports, and alerts.

AI.png

Medical Decisions are made based on a precise AI analysis.

Cost effient.png

The mechatronic response is constantly depreciating pressure improving medical care teams' time-consuming.

add-on unit.png

The Add-on unit converts any bed to a smart bed.

Calander.png

With a high patient turnover by preventing pressure ulcers, the patients' healing time is shorter. 

 
LOGO.png

Diagnostics Module 

AI-powered diagnostic software that captures and converts precise body pressure measurements into an output signal and provides real-time body infographic information.

.

 

Mapping.png

The secured cloud-based data monitoring display, alert, and analyze data from surface performance and recorded monitoring scenarios.

 

The AI generates a big data cross-analysis In order to provide the medical staff precise data insights to make an evidence-based treatment plan to improve the patient condition.

Benefits

data analysis.png

Cross-analysis driving information insights

Treatment proccess.png

Improving treatment management process

adjusted treatment.png

Improving personalized treatment

 
 
LOGO.png

Strategic Cooperations

Smart beds market value in hospitals and Rehabilitation centers is projected to be USD 1.8 Billion in 2026.

To meet customer demand for cutting-edge smart beds, companies are focused on expanding their product ranges and introducing innovative technologies and new product developments.

 

The companies have adopted organic as well as inorganic growth to expand their product portfolio and increase their respective market shares across different regions.

 

RMD solutions can be of great value to smart bed manufacturer key players. It can strengthen both their product portfolio and industry position.

 

 

Benefits

new Technology.png
Market share.png
Enlarge protfolio.png
add-on.png

 Growth of innovative technology products. Converting any bed to a smart bed with AI-based insights

The add on unit can be an addition to smart beds, or a replacement to all treatment mattresses

Expanding the  products portfolio enables  companies to penetrate monitoring-based products markets

The add-on unit can be easily integrated into existing production lines and logistics

LOGO.png

From Professor Yosef Haik

Head of Sheba Burn Intensive Care Unit

 
 
LOGO.png

The Team

SHELLY.jpg.png
UDI.png
4.png
dean adel.png

Shelly Agassi

CEO

Expert in business operation. Providing a managerial platform for business growth, by formulating a  strategic plan for achieving goals.

Udi Ginati

Chairman

Udi Ginati is leading the fundraising operations. With 24  years of entrepreneurship experience in the areas of banking.

Prof. Yossef Haik.

Chief of Science

Specialist in Plastic & Aesthetic Surgery. Director of the Plastic Surgery Division and the National Burn Intensive Care Unit at Sheba Medical Center,

Prof. Deal Adel

Clinical Affairs

Director of the Department of Plastic Surgery since 2004, Beilinson, Sharon, and Schneider hospitals, served as visiting professor.

Carmeli.png
3.png
9.png
1.png

Professor Eli Carmeli

Clinical Affairs

Menachem Tziegfnger

CTO

Doron Yechezkel

AI Development

Eve Krispin

VP Biz-Dev

Physiotherapist, academic, lecturer, and researcher in the field of changes in skeletal muscle in old age.

Electronics engineer, led projects in a matrix organization, with a strong background in HW design of Digital, mixed-signal, and power electronics.

Software engineer, experience in planning, architecture, development, algorithms, and project management.

Strategy and business development expert focused on introducing business opportunities to business partners.

CONTACT US

Haprachim St., Ra'anana, Israel

rmd@rose-md.com

Shelly Agassi: +972-54-3382903

Udi Ginati: +972-52-3536294

Thanks for submitting!